While WT RAS of the same isoform generally inhibits tumor initiation and growth, the protein products of the two non-mutated, WT RAS genes (for example HRAS and NRAS in a KRAS-mutated cancer; hereafter called WT RAS in all cases) are tumor promoting in RAS-mutated tumors [30,50]. This evidence concerns the gene KRAS and neoplasm.